Cells

Human iPSC-Derived Neural Precursor Cells (iPSC-NPCs)

IPSCN001 Cells
$1,999.00
Human iPSC-Derived Neural Precursor Cells (iPSC-NPCs)
In Stock 1 Vial — 500,000 cells
Product Type iPSC-Neural Precursor Ce…
Viability >90% viability post-thaw
Storage Store in liquid nitrogen vapor phase (-196°C) for long-term. Ship on dry ice (-80°C).
Shelf Life Very stable in the Liquid Nitrogen Vapor Phase

Quick Actions

Quality Certified
Global Shipping Available
Technical Support Included

Product Overview

Description

Human iPSC-NPCs are highly pure, cryopreserved neural precursor cells derived from induced pluripotent stem cells (iPSCs) using a directed, serum-free differentiation protocol.

These cells exhibit robust capacity for self-renewal and multipotent differentiation into neurons, astrocytes, and oligodendrocytes. They are ideal for neurotoxicity screening, disease modeling, regenerative medicine research, and high-throughput drug discovery.

IMPORTANT: Quality warranty requires use of NeoBioPharma media. Biohazardous material despite negative pathogen testing. Quality claims must be reported within 1 month.
Source: Normal human iPSC line (fully characterized, pathogen-free)

Key Features

Catalog Number: IPSCN001
Product Format: Frozen
Vial Cell Number: 500,000 cells/vial
Passage: 1 (P1)
Storage: Liquid Nitrogen, Vapor Phase
Intended Use: Research use only (RUO)

Quick Facts
Product Type

iPSC-Neural Precursor Cells

Viability

>90% viability post-thaw

Applications

• High-throughput neurotoxicity and drug screenin…

Availability

In Stock • Global Shipping

Technical Specifications

Product Type
iPSC-Neural Precursor Cells
Viability
>90% viability post-thaw
Storage Conditions
Store in liquid nitrogen vapor phase (-196°C) for long-term. Ship on dry ice (-80°C).
Shelf Life
Very stable in the Liquid Nitrogen Vapor Phase
Product Code
IPSCN001
Size/Format
1 Vial — 500,000 cells
Primary Applications
• High-throughput neurotoxicity and drug screening. • Alzheimer’s Parkinson’s and schizophrenia disease modeling. • Co-culture with microglia or endothelial cells (BBB model). • Neural differentiation protocol development. • CRISPR/Cas9 genome editing for neurodegenerative disease research.

Applications & Use Cases

Primary Applications
• High-throughput neurotoxicity and drug screening. • Alzheimer’s

Suitable for • high-throughput neurotoxicity and drug screening. • alzheimer’s studies and research applications

Parkinson’s

Suitable for parkinson’s studies and research applications

and schizophrenia disease modeling. • Co-culture with microglia or endothelial cells (BBB model). • Neural differentiation protocol development. • CRISPR/Cas9 genome editing for neurodegenerative disease research.

Suitable for and schizophrenia disease modeling. • co-culture with microglia or endothelial cells (bbb model). • neural differentiation protocol development. • crispr/cas9 genome editing for neurodegenerative disease research. studies and research applications

Research Areas
In Vitro Studies

Cell culture and screening applications

Molecular Biology

Gene expression & signaling studies

Drug Discovery

Screening & validation studies

Disease Modeling

Pathophysiology research

Support & Resources

Technical Support

Our experts are available for technical questions and protocol assistance.

Contact Support
Documentation

Access product datasheets, protocols, and certificates.

Request Documentation
Shipping & Logistics

Temperature-controlled shipping to 40+ countries worldwide.

Shipping Info
FAQ & Resources

Find answers to common questions and optimization tips.

View FAQs

Our Worldwide Locations

Find a distributor near you

Harmony Biosolution Inc.

Harmony Biosolution Inc.

Address 1F., No. 309-4, Sec. 1,
Wenhua Rd.,
Banqiao Dist.,, New Taipei City, 220
Taiwan
MoreBio

MoreBio

Advancing Life Science, Globally

Address F810, Testa Tower, 25, Misagangbyeonseo-ro
Hanam-si, Gyeonggi-do, Republic of Korea, 12918
Korea
Contact yhwoo@morebio.co.kr
+82-2-406-2942
+82-31-735-2944